Literature DB >> 3128996

Genital ulceration as a risk factor for human immunodeficiency virus infection.

R M Greenblatt1, S A Lukehart, F A Plummer, T C Quinn, C W Critchlow, R L Ashley, L J D'Costa, J O Ndinya-Achola, L Corey, A R Ronald.   

Abstract

Among 115 heterosexual men who presented with genital ulcers to a sexually transmitted disease clinic in Nairobi, Kenya, the prevalence of serum antibody to HIV was 16.5%. A past history of genital ulcers was reported by 12 (63%) of 19 men with antibody to HIV versus 30 (31%) of 96 without antibody (P = 0.008). HIV infection was also positively associated with lack of circumcision, but was not associated with the etiology of the current genital ulcer. Logistic regression analysis (adjusted for age, number of recent sex partners, recent prostitute contact, circumcision, tribal ethnic identity, past history of urethritis, and current diagnoses) confirmed only the association between prior history of genital ulcer disease and HIV infection; (P = 0.04, odds ratio 2.35, 95% confidence limits, 1.01-5.47). The incidence of genital ulcers, particularly chancroid, is much higher in parts of Africa than in Europe or North America. This may contribute to the increased risk of heterosexual transmission of HIV in Africa. Aggressive control of chancroid and syphilis may offer one very feasible approach to reducing transmission of HIV in this region.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Antibodies--analysis; Biology; Data Analysis; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Genital Effects, Male; Genitalia; Genitalia, Male; Hiv Infections; Immunity; Immunologic Factors; Kenya; Physiology; Research Methodology; Risk Factors; Urogenital Effects; Urogenital System; Viral Diseases

Mesh:

Year:  1988        PMID: 3128996     DOI: 10.1097/00002030-198802000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  94 in total

1.  Development of a serological test for Haemophilus ducreyi for seroprevalence studies.

Authors:  C Elkins; K Yi; B Olsen; C Thomas; K Thomas; S Morse
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 2.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 3.  Immunological functions of the human prepuce.

Authors:  P M Fleiss; F M Hodges; R S Van Howe
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

4.  Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.

Authors:  X Da Costa; M F Kramer; J Zhu; M A Brockman; D M Knipe
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 5.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

6.  Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Authors:  Robert A Fulcher; Leah E Cole; Diane M Janowicz; Kristen L Toffer; Kate R Fortney; Barry P Katz; Paul E Orndorff; Stanley M Spinola; Thomas H Kawula
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Haemophilus ducreyi, a cytotoxin-producing bacterium.

Authors:  M Purvén; T Lagergård
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 8.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 9.  Sexually transmitted diseases in Africa.

Authors:  A S Latif
Journal:  Genitourin Med       Date:  1990-08

10.  Cloning and characterization of tdhA, a locus encoding a TonB-dependent heme receptor from Haemophilus ducreyi.

Authors:  C E Thomas; B Olsen; C Elkins
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.